Cargando…
Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions
The effective development of innovative surgical applications and immunosuppressive agents have improved remarkable advancements in solid organ transplantation. Despite these improvements led to prevent acute rejection and to promote short-term graft survival, the toxicity of long-term immunosuppres...
Autores principales: | Fortunato, Marta, Morali, Konstantina, Passeri, Laura, Gregori, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940680/ https://www.ncbi.nlm.nih.gov/pubmed/33708227 http://dx.doi.org/10.3389/fimmu.2021.641596 |
Ejemplares similares
-
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
por: Gregori, Silvia, et al.
Publicado: (2015) -
Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells
por: Safinia, Niloufar, et al.
Publicado: (2018) -
Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation
por: Orozco, Gabriel, et al.
Publicado: (2022) -
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation
por: Sanders, Jes M., et al.
Publicado: (2022) -
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
por: Comi, Michela, et al.
Publicado: (2020)